200 related articles for article (PubMed ID: 16890957)
1. Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils.
Hatters DM; Zhong N; Rutenber E; Weisgraber KH
J Mol Biol; 2006 Sep; 361(5):932-44. PubMed ID: 16890957
[TBL] [Abstract][Full Text] [Related]
2. The structure of human apolipoprotein E2, E3 and E4 in solution. 2. Multidomain organization correlates with the stability of apoE structure.
Clément-Collin V; Barbier A; Dergunov AD; Visvikis A; Siest G; Desmadril M; Takahashi M; Aggerbeck LP
Biophys Chem; 2006 Jan; 119(2):170-85. PubMed ID: 16125836
[TBL] [Abstract][Full Text] [Related]
3. Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide.
Stratman NC; Castle CK; Taylor BM; Epps DE; Melchior GW; Carter DB
Chem Phys Lipids; 2005 Oct; 137(1-2):52-61. PubMed ID: 16140289
[TBL] [Abstract][Full Text] [Related]
4. Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes.
Rapp A; Gmeiner B; Hüttinger M
Biochimie; 2006 May; 88(5):473-83. PubMed ID: 16376010
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein-E modulates the cytotoxic effect of beta-amyloid on rat brain endothelium in an isoform-dependent specific manner.
Folin M; Baiguera S; Guidolin D; Di Liddo R; Grandi C; De Carlo E; Nussdorfer GG; Parnigotto PP
Int J Mol Med; 2006 May; 17(5):821-6. PubMed ID: 16596266
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations.
Moir RD; Atwood CS; Romano DM; Laurans MH; Huang X; Bush AI; Smith JD; Tanzi RE
Biochemistry; 1999 Apr; 38(14):4595-603. PubMed ID: 10194381
[TBL] [Abstract][Full Text] [Related]
7. Structural variation manipulates the differential oxidative susceptibility and conformational stability of apolipoprotein E isoforms.
Su KL; Wen TH; Chou CY; Chang GG; Liu GY; Hung HC
Proteins; 2007 Jul; 68(1):363-74. PubMed ID: 17410580
[TBL] [Abstract][Full Text] [Related]
8. Isoform-specific effect of apolipoprotein E on endocytosis of beta-amyloid in cultures of neuroblastoma cells.
Yamauchi K; Tozuka M; Hidaka H; Nakabayashi T; Sugano M; Katsuyama T
Ann Clin Lab Sci; 2002; 32(1):65-74. PubMed ID: 11848621
[TBL] [Abstract][Full Text] [Related]
9. Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta.
Morikawa M; Fryer JD; Sullivan PM; Christopher EA; Wahrle SE; DeMattos RB; O'Dell MA; Fagan AM; Lashuel HA; Walz T; Asai K; Holtzman DM
Neurobiol Dis; 2005; 19(1-2):66-76. PubMed ID: 15837562
[TBL] [Abstract][Full Text] [Related]
10. ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42.
Trommer BL; Shah C; Yun SH; Gamkrelidze G; Pasternak ES; Stine WB; Manelli A; Sullivan P; Pasternak JF; LaDu MJ
Neurobiol Dis; 2005 Feb; 18(1):75-82. PubMed ID: 15649697
[TBL] [Abstract][Full Text] [Related]
11. Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E.
Wood SJ; Chan W; Wetzel R
Biochemistry; 1996 Sep; 35(38):12623-8. PubMed ID: 8823200
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli.
Morrow JA; Arnold KS; Weisgraber KH
Protein Expr Purif; 1999 Jul; 16(2):224-30. PubMed ID: 10419818
[TBL] [Abstract][Full Text] [Related]
13. Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution.
Chou CY; Lin YL; Huang YC; Sheu SY; Lin TH; Tsay HJ; Chang GG; Shiao MS
Biophys J; 2005 Jan; 88(1):455-66. PubMed ID: 15475580
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases.
Huang Y
Curr Opin Lipidol; 2010 Aug; 21(4):337-45. PubMed ID: 20531185
[TBL] [Abstract][Full Text] [Related]
15. The endosomal trafficking of apolipoprotein E3 and E4 in cultured human brain neurons and astrocytes.
DeKroon RM; Armati PJ
Neurobiol Dis; 2001 Feb; 8(1):78-89. PubMed ID: 11162242
[TBL] [Abstract][Full Text] [Related]
16. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction.
Wang H; Durham L; Dawson H; Song P; Warner DS; Sullivan PM; Vitek MP; Laskowitz DT
Neuroscience; 2007 Feb; 144(4):1324-33. PubMed ID: 17187933
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro.
Raftery M; Campbell R; Glaros EN; Rye KA; Halliday GM; Jessup W; Garner B
Biochemistry; 2005 May; 44(19):7346-53. PubMed ID: 15882073
[TBL] [Abstract][Full Text] [Related]
18. The structure of human apolipoprotein E2, E3 and E4 in solution 1. Tertiary and quaternary structure.
Barbier A; Clément-Collin V; Dergunov AD; Visvikis A; Siest G; Aggerbeck LP
Biophys Chem; 2006 Jan; 119(2):158-69. PubMed ID: 16139946
[TBL] [Abstract][Full Text] [Related]
19. Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies.
Huang Y
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):627-41. PubMed ID: 17002223
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cell proliferation by apolipoprotein E isoform expression.
Chan WM; Ho YY
Arch Biochem Biophys; 2006 Jul; 451(2):97-102. PubMed ID: 16780788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
